Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Non-Current Deferred Tax Liability (2023 - 2025)

Coherus Oncology (CHRS) has disclosed Non-Current Deferred Tax Liability for 3 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability changed 0.0% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $1.1 million for FY2025, 0.0% changed from the prior year.
  • Non-Current Deferred Tax Liability hit $1.1 million in Q4 2025 for Coherus Oncology, roughly flat from $1.1 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.1 million in Q3 2023 to a low of $1.1 million in Q3 2023.
  • Historically, Non-Current Deferred Tax Liability has averaged $1.1 million across 3 years, with a median of $1.1 million in 2023.
  • Biggest YoY gain for Non-Current Deferred Tax Liability was 0.0% in 2024; the steepest drop was 0.0% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $1.1 million in 2023, then changed by 0.0% to $1.1 million in 2024, then changed by 0.0% to $1.1 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for CHRS at $1.1 million in Q4 2025, $1.1 million in Q3 2025, and $1.1 million in Q2 2025.